Stonehage Fleming Financial Services’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.5K Hold
2,551
﹤0.01% 175
2026
Q1
$48.9K Hold
2,551
﹤0.01% 189
2025
Q4
$56.1K Hold
2,551
﹤0.01% 186
2025
Q3
$31K Hold
2,551
﹤0.01% 192
2025
Q2
$47.5K Hold
2,551
﹤0.01% 180
2025
Q1
$48.9K Hold
2,551
﹤0.01% 153
2024
Q4
$91.9K Buy
+2,551
New +$86.3K ﹤0.01% 164

Other funds holding TNDM

Stonehage Fleming Financial Services's TNDM Position: Q2 2026 in Review

Stonehage Fleming Financial Services held its Tandem Diabetes Care (TNDM) position steady in Q2 2026 at 2,551 shares worth $38.5K. The position accounts for ﹤0.01% of the portfolio, ranked #175.

Stonehage Fleming Financial Services first reported a position in TNDM in Q4 2024 and has held it in 7 quarters since. The position peaked at $91.9K in Q4 2024. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Stonehage Fleming Financial Services held 2,551 shares of Tandem Diabetes Care worth $38.5K as of Q2 2026.
  • Stonehage Fleming Financial Services left its Tandem Diabetes Care share count unchanged in Q2 2026.
  • Tandem Diabetes Care made up ﹤0.01% of Stonehage Fleming Financial Services's portfolio in Q2 2026, its #175 holding.
  • Stonehage Fleming Financial Services first reported a position in Tandem Diabetes Care in Q4 2024 and has held it in 7 quarters since.
  • Stonehage Fleming Financial Services's Tandem Diabetes Care position peaked at $91.9K in Q4 2024.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Stonehage Fleming Financial Services's 13F filing for Q2 2026, filed 17 Aug 2026.